CA1054520A - L-ascorbic acid tablets - Google Patents

L-ascorbic acid tablets

Info

Publication number
CA1054520A
CA1054520A CA249,080A CA249080A CA1054520A CA 1054520 A CA1054520 A CA 1054520A CA 249080 A CA249080 A CA 249080A CA 1054520 A CA1054520 A CA 1054520A
Authority
CA
Canada
Prior art keywords
ascorbic acid
weight percent
granules
weight
binder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA249,080A
Other languages
English (en)
French (fr)
Inventor
Nobuyuki Kitamori
Tadashi Makino
Keizi Hemmi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50090742A external-priority patent/JPS58403B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of CA1054520A publication Critical patent/CA1054520A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA249,080A 1975-07-24 1976-03-29 L-ascorbic acid tablets Expired CA1054520A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50090742A JPS58403B2 (ja) 1975-07-24 1975-07-24 L− アスコルビンサンセイザイノ セイゾウホウ
US05/610,003 US4036948A (en) 1975-07-24 1975-09-03 L-ascorbic acid tablets

Publications (1)

Publication Number Publication Date
CA1054520A true CA1054520A (en) 1979-05-15

Family

ID=26432181

Family Applications (1)

Application Number Title Priority Date Filing Date
CA249,080A Expired CA1054520A (en) 1975-07-24 1976-03-29 L-ascorbic acid tablets

Country Status (8)

Country Link
CA (1) CA1054520A (es)
DE (1) DE2616078C2 (es)
ES (1) ES446464A1 (es)
FR (1) FR2318621A1 (es)
GB (1) GB1534066A (es)
HK (1) HK2182A (es)
MX (1) MX3239E (es)
NL (1) NL184308C (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5759803A (en) * 1980-09-30 1982-04-10 Takeda Chem Ind Ltd Granule of l-sodium ascorbate, its preparation, and tablet comprising it
WO1989006643A1 (en) * 1988-01-22 1989-07-27 Kharkovsky Nauchno-Issledovatelsky Institut Endokr UNDECYLIC ETHER n-CHLOROPHENOXYISOBUTYRIC ACID AND A PHARMACEUTICAL PREPARATION FOR TREATING HYPERLIPEMIA BASED ON IT
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
JP4098376B2 (ja) * 1996-09-05 2008-06-11 ビーエーエスエフ ソシエタス・ヨーロピア 錠剤特性の優れた水溶性ビタミン組成物およびその製造法
DE19733094A1 (de) * 1997-07-31 1999-02-04 Merck Patent Gmbh Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453368A (en) * 1966-01-13 1969-07-01 Hoffmann La Roche Smaller high potency compressed tablets of ascorbic acid

Also Published As

Publication number Publication date
ES446464A1 (es) 1977-10-16
NL7602657A (nl) 1977-01-26
MX3239E (es) 1980-08-06
FR2318621A1 (fr) 1977-02-18
NL184308B (nl) 1989-01-16
FR2318621B1 (es) 1979-03-30
DE2616078C2 (de) 1985-05-15
GB1534066A (en) 1978-11-29
DE2616078A1 (de) 1977-02-10
NL184308C (nl) 1989-06-16
HK2182A (en) 1982-01-22

Similar Documents

Publication Publication Date Title
US4036948A (en) L-ascorbic acid tablets
CA1244768A (en) Sugar and starch free spray-dried vitamin c powder containing 90 percent ascorbic acid
US5047248A (en) Formulation for preparing sustained release drugs for oral administration
US4072535A (en) Precompacted-starch binder-disintegrant-filler material for direct compression tablets and dry dosage capsules
US3622677A (en) Compressed tablets containing compacted starch as binder-disintegrant ingredient
EP0487774B1 (en) A direct tabletting auxiliary
US4427648A (en) Dipyridamole-containing pharmaceutical form
US4702919A (en) Granules of thiamine salt and the production thereof
US4372968A (en) Granules of sodium ascorbate and the production thereof
CA1261261A (en) Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
AU2006260201B2 (en) Tablet containing hardly soluble active ingredient
CN109432022B (zh) 一种含酒石酸伐尼克兰的药物组合物及其制备方法
JP2017520627A (ja) コロイドビスマスペクチンを含有する分散製剤及びその製造方法
CN112494445A (zh) 一种马来酸氟伏沙明组合物及其制备方法
US4520009A (en) Sustained released aspirin formulation
CA1054520A (en) L-ascorbic acid tablets
EP0196546B1 (en) Pharmaceutical tableting method
EA000913B1 (ru) Таблетка меченной изотопом мочевины
US5334393A (en) Sustained-release tablet based on isosorbide 5-mononitrate and process for preparing it
JPS63290818A (ja) 高分子量ヒドロキシプロピルメチルセルロースを基剤にした徐放性錠剤
DE3045488C2 (es)
JPH04128221A (ja) 鎮痛剤組成物およびその組成方法
CN106176655B (zh) 一种青霉素v钾片及其制备工艺
US5534551A (en) Aminoguanidine spray drying process
Klinger et al. Formulation of controlled release matrices by granulation with a polymer dispersion